Introduction to RNA Vaccines
Self-replicating RNA
Self-replicating RNA Vaccine Delivery to Dendritic Cells
Plant Expression of Trans-encapsidated Viral Nanoparticle Vaccines with Animal RNA Replicons
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines
Nucleoside Modified mRNA Vaccines for Infectious Diseases
Generation and Evaluation of Prophylactic mRNA Vaccines against Allergy
Measuring the Adjuvant Activity of RNA Vaccines
Generation of Immunostimulating 130 nm Protamine-RNA Nanoparticles
Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins
Adjuvant-Enhanced mRNA Vaccines
Enhanced Delivery of DNA or RNA Vaccines by Electroporation
The European Regulatory Environment of RNA-Based Vaccines
Discovery and Subtyping of Neo-Epitope Specific T-cell Responses for Cancer Immunotherapy: Addressing the Mutanome
Considerations for Producing mRNA Vaccines for Clinical Trials
Nonclinical Safety Testing of RNA Vaccines
Immunotherapy of Uveal Melanoma: Vaccination Against Cancer.